Table of Content



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Heart Transplant Rejection - Overview
Heart Transplant Rejection - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Heart Transplant Rejection - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Heart Transplant Rejection - Companies Involved in Therapeutics Development
Astellas Pharma Inc
Kiniksa Pharmaceuticals Ltd
Nekol Sarl
Noxxon Pharma AG
Heart Transplant Rejection - Drug Profiles
AS-2521780 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AS-2553627 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
emapticap pegol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KPL-404 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit TIRC-7 for Cardiac and Kidney Transplantation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Heart Transplant Rejection - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures



Number of Products under Development for Heart Transplant Rejection, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables



Number of Products under Development for Heart Transplant Rejection, H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Heart Transplant Rejection - Pipeline by Astellas Pharma Inc, H1 2020
Heart Transplant Rejection - Pipeline by Kiniksa Pharmaceuticals Ltd, H1 2020
Heart Transplant Rejection - Pipeline by Nekonal Sarl, H1 2020
Heart Transplant Rejection - Pipeline by Noxxon Pharma AG, H1 2020
Heart Transplant Rejection - Dormant Projects, H1 2020